供应链分析
产业链结构、上下游与瓶颈环节研究 · 共 1413 条 · 滚到底自动加载更多
-
指出SK海力士、三星、闪迪及美光的存储瓶颈问题持续存在。
匿名者，$SHKY、三星、$SNDK、$MU 的存储瓶颈从未改变 https://t.co/6Xyih3pM9D
英文原文
The $SHKY, Samsung, $SNDK, $MU memory bottleneck never changed anon https://t.co/6Xyih3pM9D
-
特朗普签署行政令对无人机加征关税，利好本土供应链。
唐纳德·特朗普签署行政令，以加强美国无人机供应链。 利好美国无人机组件供应商如 $UMAC，以及无人机系统(UAS)制造商如 $ONDS 和 $RCAT。 简而言之，100% 关税适用于： - UAS 停机坪及某些关键组件 - 25 公斤以上无人机的某些部件 - 25 公斤以上的无人机 25% 关税适用于： - 更广泛的组件 UAS = 无人机系统（我在上述任何标的中均无持仓）
英文原文
Donald Trump signs a proclamation to strengthen US supply chains for drones. Benefiting U.S. drone component suppliers like $UMAC to UAS manufacturers like $ONDS + $RCAT. TLDR, 100% tariffs on: - UAS docking stations + certain critical components - certain parts for >25 kg drones - Drones >25 kg 25% tariffs on: - broader components UAS = Unmanned Aircraft System (don't have any positions in any above)
-
三星与SKC推迟玻璃基板量产，相关供应商放量节奏随之延后。
感觉玻璃基板（Glass Substrate）的时间表又推迟了至少一个季度。 - “三星电机（Samsung Electro-Mechanics）推迟半导体玻璃基板投资”，原因是原型机在客户可靠性评估环节遇到瓶颈。 在最近不到一个月前的第二季度财报演示中，该公司将投产时间修订为2028年。 - “SKC据报道将玻璃基板量产推迟至2027年，目标年底前完成最终验证”（Trendforce），这是上个月早些时候的消息。 总结： - SKC Absolics 从2026年下半年推迟至2027年上半年 - 三星从2027年下半年推迟至2028年上半年 时间表的变动并不总是好消息，但玻璃核心基板（Glass Core Substrate）的转变似乎迫在眉睫。 部分玩家如 $LPK / Philoptics (161580) / E&R (8027) 的放量节奏可能跟随这些量产时间表。
英文原文
Feels like glass substrate timelines got pushed back at least another quarter. - "Samsung Electro-Mechanics Delays Semiconductor Glass Substrate Investment" due to a bottleneck in customer reliability evaluations of prototypes. At its recent second-quarter earnings presentation, less than a month later, the company revised the start of operations to 2028. - "SKC Reportedly Pushes Glass Substrate Mass Production to 2027, Targets Final Validation by Year-end" (Trendforce), earlier last month. TLDR: - SKC Absolics H2 2026 -> H1 2027 - Samsung H2 2027 -> H1 2028 Not everything is always good news with timeline shifts, but glass core substrate shifts do feel imminent. Volume ramp for some players eg. $LPK / Philoptics (161580) / E&R (8027) likely track these mass production timelines.
-
点评Vantage、Anthropic等IPO估值，质疑Anthropic并看好Unitree。
IPO新闻……Vantage Data Centers正考虑以惊人的1000亿美元估值上市。如果不熟悉，$ORCL是Stargate（OpenAI终端用户）的锚定租户，Vantage开发/运营超大规模数据中心。Anthropic也预计IPO，据FT报道，投资者预期其估值达2万亿美元，超越$SPCX。嗯……我对Anthropic的估值持保留态度。Jim Cramer为这种估值辩护从来都不是好兆头。顺便说一句，Opus 5大概是我用过的最差的消费级大语言模型(LLM)，它就像一个智商只有5的LLM，基于糟糕的数据检索运行，还带着一种类似《神偷》(Fable)游戏里的上帝情结。不过企业端可能体验更好。Unitree也预计本月IPO，估值90亿美元。这对人形机器人板块是积极的风口。SHEIN不是AI概念股，但将于本月19日尽快上市。去问问你认识的任何女孩，她们可能都熟悉这个平台。
英文原文
In IPO news… Vantage Data Centers is exploring going public at an enormous $100B valuation. If you’re not familiar, $ORCL is their anchor tenant for Stargate (OpenAI end user), and Vantage develops/operates hyperscaler DCs. Anthropic IPO is also expected, with investors expecting $2T valuation, eclipsing $SPCX per FT. Yeah… idk about Anthropic valuations. Jim Cramer defending that valuation is never a good sign. On a side note, Opus 5 is probably the worst consumer LLM I’ve used to date, it’s like a 5 IQ LLM operating off terrible data retrieval. With a Fable-like God complex on top. Enterprise is probably having a better time though. Unitree IPO is also expected this month and priced it at a $9B valuation. Which is a positive tailwind for Unitree for the humanoid sectors. Not really an AI name but SHEIN is going public as soon as the 19th this month. Go ask any girl you know and they’re probably familiar with this platform.
-
CW激光器供需失衡严重，成AI供应链关键瓶颈。
@blkslymn 我不确定是不是只有我这么看，但我现在正看到巨大的连续波(CW)需求失衡（感谢 $NVDA）。这还是在规模扩展(scale up)和其他 1.6T 产品量产甚至到来之前。然后 $AAOI 和 $SIVE 出现了，它们拥有稀缺且独立的 CW 激光器或光模块产能……这通常会导致其他主要玩家如 $AMD 和超大规模云厂商转向关注它们。$MTSI 表示他们的产能要到 2027 年下半年才开始上线，而客户已经带着紧迫感向他们接洽……CW 激光器是我目前最看好的瓶颈之一。
英文原文
@blkslymn I'm not sure if it's just me, but I'm just seeing enormous CW demand imbalance right now (thank you $NVDA). And this is before scale up and other 1.6T ramps even arrive. Then you have $AAOI and $SIVE appear with scarce, independent CW laser or transceiver capacity... That usually leads forces your other major players like $AMD and hyperscalers to look at them. $MTSI said their capacity only starts to come online H2 2027 and customers are already approaching them with urgency... CW lasers is one of my favorite bottlenecks right now.
-
推测 SIVE 或整合新技术，为 CPO 提供高功率多波长光引擎。
@dankdrankkz Sivers 发现了一家去年完成 B 轮 300 万美元融资的小型公司，据称其单发射器功率已达 200-250 瓦。$SIVE 或许可以将其与高波长 DFB 阵列相结合，打造出例如 8/16 × 200-250 瓦的超高功率产品，以实现极高的总输出功率。该项目的重点在于共封装光学(CPO)对“更高功率、更多波长”的需求，这是我的猜测。
英文原文
@dankdrankkz Sivers found a small Series B company that raised $3m last year that achieved 200-250mw per emitter apparently. $SIVE can maybe combine that with their high wavelength DFB array, and maybe make something extremely high power like eg. 8/16 × 200-250mw for high aggregate output. Program was focused on "need for higher power, more wavelengths" for CPO, so that's my guess.
-
基于财报指出CPO量产最早时间点，认为具体时间表极具看多意义。
@JoelLikesTurtle 如果你查看 $LITE 和 $COHR 的财报，共封装光学(CPO) 实现规模化量产的最早时间框架确实就是现在。而且给出如此具体的时间框架实际上是非常看多(bullish)的。
英文原文
@JoelLikesTurtle That's literally the earliest timeframe possible for CPO scale up early volumes if you look at $LITE and $COHR earnings. And giving that specific timeframe is actually extremely bullish.
-
SIVE与SemiNex合作开发CPO组件，旨在通过早期合作降低风险。
$SIVE 宣布与 SemiNex 达成 340 万美元的开发计划！ 针对共封装光学(CPO)、分布反馈(DFB)激光阵列和光放大器。 早期生产目标定于 2027 年下半年（与 CPO 早期规模化时间表一致） 起初我觉得这有点奇怪，考虑到产品重叠，因为 SemiNex 是一家规模小得多的 B 轮公司…… 但随后我想起了 $SPCX 与 Cursor 关系的弱化版（通过先合作来降低风险）。 Sivers 在这家公司里可能发现了有趣的东西。
英文原文
$SIVE announces a $3.4M development program with SemiNex! For CPO, DFB laser arrays, and optical amplifiers. Early production is targeted H2 2027 (in line with early scale up CPO timelines) Seemed weird to me at first given product overlap, since SemiNex is a much smaller Series B company... But then I got reminded of a less explicit version of $SPCX + Cursor relationship (derisking by working together first). There's probably something interesting Sivers found in this company.
-
CW激光器供应商如SIVE等未来重要性将显著提升。
@stockprodigyman 我的结论是，$SIVE / Win、住友、古河以及其他合格的CW（连续波）商用激光器供应商…… 在未来将变得重要得多。
英文原文
@stockprodigyman My takeaway was that $SIVE / Win, Sumitomo, Furukawa, and other qualified CW merchant laser suppliers... Are going to become a lot more important in the near future.
-
COHR财报揭示InP激光器产能紧缺，CPO需求提前，收入高增。
我的主要观点是：商用连续波(CW)激光器供应商现在显得极其重要。 但 $COHR 财报的 TLDR（太长不看版）是： “鉴于我们在数据中心业务中看到的收发器需求，我认为在可预见的未来，我们都不会对外销售磷化铟(InP)激光器。” - 如果 $AAOI 无法为第一代共封装光学(CPO)部署提供足够产能，且 $COHR 不对外销售，那么那些对外销售 InP 激光器的公司将获得更高的估值。 我想这就是为什么 $MTSI 表示大量客户正迫切地向他们寻求 InP CW DFB 激光器（而他们直到 2027 年底才没有有意义的产能上线）。 $AAOI -> 内部自用 $COHR -> 内部自用 买家 -> 寻找产能的选择更少。 “我们的积压订单现已延伸至 2027 财年，基本上已完全预订。我们实际上已预订至 2027 日历年末。” [巨大的需求可见性] - Coherent 还提到了跨越至本十年末的长期协议(LTA)。这在一定程度上印证了 $POET CEO 在其年度股东大会上所说的“三大巨头”未来两年已完全售罄。 “我们目前在组装和测试产能方面并不受限。我们真正受限的是磷化铟生产的爬坡。” - 对于那些关注瓶颈的兄弟们来说，组装/测试并不是瓶颈。 “CPO 需求绝对没有推迟。事实上，情况恰恰相反。我们看到了需求增加，客户的要求被提前。” “我们继续预计来自规模化应用的 CPO 收入将从 2027 年日历年下半年开始流入。” - 如果 $LITE 和 $COHR 确认 CPO 规模化收入将在 2027 年下半年到来，这对其他 CPO 参与者来说是一个巨大的利好传导。 - “到 2027 财年末，季度收入超过 30 亿美元” - $COHR 收入飞速增长 所以常规数据如下： - 收入 20.46 亿美元（环比 +13.3%，同比 +33.8%），主要收入增长看起来发生在进入 Q4 至 2027 年期间 - 非公认会计准则毛利率：40.2% 下一季度指引为： - 收入：22-24 亿美元 - 非公认会计准则毛利率：39.5-41.5% 基本上： 16.9 亿 -> 18.1 亿 -> 20.5 亿 -> ~23.0 亿 -> 30 亿（2027 财年末） ~39% -> 39.6% -> 40.2% -> ~40.5%（毛利率） 对于营业利润率： 18.0% -> 19.5% -> 19.9% -> 20.3% -> 21.8% 与 $LITE 的利润率增长相比，我对盈利能力的印象稍逊一筹，但 $COHR 的收入规模正在快速增长。
英文原文
My main takeaway was that your merchant CW laser suppliers seem to be EXTREMELY IMPORTANT now. But TLDR of $COHR earnings: "given the demand that we see in our DC business with transceivers, I don’t see any time in the near future where we would be selling indium phosphide lasers externally" - Ton more value placed on companies that sell InP lasers externally if $AAOI can't doesn't enough capacity for first gen-CPO deployments, $COHR not selling externally... I guess that's why $MTSI said a ton of customers are approaching them with urgency for InP CW DFB lasers (and they dont even have meaningful capacity coming online until EOY 2027) $AAOI -> Internal $COHR -> Internal Buyers -> fewer places to look for capacity. "Our backlog now extends out, fiscal 2027 is basically completely booked out. We are booked really through the end of calendar 2027" [ Massive massive demand visibility] - Coherent also mentioned LTAs spanning end of decade. So this kinda reinforces what $POET CEO said at their AGM that the "big 3" are fully sold out next 2 years. "we’re not constrained in the assembly and test capacity right now. We’re really just constrained by the ramp of the indium phosphide production" - Just for the bottleneck bros in terms of assembly/test not a bottleneck. "absolutely no push-out of CPO demand. In fact, it has been the opposite. We have seen demand increase and request from customers’ demand getting pulled in" "we continue to expect revenue from CPO for scale-up applications to start to flow in the second half of calendar 2027" - Big read through on other CPO players for scale up if $LITE, $COHR reaffirm revenue from CPO scale up coming h2027. - "quarterly revenue exceeding $3 billion by the end of fiscal 2027" - $COHR revenue go brrr So for regular numbers it's: - $2.046B revenue (+13.3% Q/Q, +33.8% Y/Y), main revenue ramp looks to be happening entering Q4 into 2027 - Non-GAAP gross margins: 40.2% Next quarter guide is: - Revenue: $2.2–$2.4B revenue - Non-GAAP gross margins: 39.5-41.5% Basically: $1.69B -> $1.81B -> $2.05B -> ~$2.30B -> $3.0B (end of FY 2027) ~39% -> 39.6% -> 40.2% -> ~40.5% (gross margins) For operating margins: 18.0% -> 19.5% -> 19.9% -> 20.3% -> 21.8% Little less impressed compared to $LITE margin growth in terms of profitability, but revenue scale for $COHR growing rapidly.
-
澄清Win Semi自行采购衬底，并指出其在台拥有多元外延代工渠道。
@Mathieuber61726 不完全是，我很确定 Win Semi（胜科半导体）自行采购其材料/衬底供应。鉴于其在台湾的地位，Win 可能与 Landmark 等外延晶圆代工厂关系密切，从而拥有额外的采购渠道。
英文原文
@Mathieuber61726 Not really, I'm pretty sure Win Semi procures their own material/substrate supply. Given it's position in Taiwan, Win is probably well connected to epi foundries like Landmark for additional sourcing options.
-
光通信财报验证CW激光器瓶颈，SIVE作为稀缺CPO标的获看好。
这就是我目前看到的关于 $SIVE 和连续波(Continuous Wave, CW)分布反馈(DFB)激光器瓶颈的情况。 来自光通信板块的财报： 1. $LITE：UHP CW 激光器出现意外需求和供需失衡。 - 有能力提高激光器的平均售价(ASP)。 - 共封装光学(CPO)扩产按计划进行，预计2027年下半年出货，称任何关于CPO扩产延迟的谣言都是噪音。 Lumentum 确认了时间表（此前 Sivers 因误导性报告被抛售），高利润率，以及经过认证的CW激光器需求极度旺盛。 2. $AAOI：由于光模块需求过大，CW 激光器产能不足。 - 并未实质性参与第一代 CPO 部署，$MTSI 看起来也不在其中，专注于非平面光学(NPO)。在 $SMTC 收购 HieFo 后，我没看到太多动静。 - 称激光器是光模块20-40%需求失衡中的瓶颈。 - 称客户每周都来找他们要求供货并加快进度。 AOI 确认了需求失衡 + 激光器瓶颈。第一代 CPO 玩家池子更小。 3. $AAOI 和 $LITE 均称中国玩家在 CPO 激光器方面落后数年，且实际认证产能远落后于其声称。 - $AAOI 称落后2-3年以上。 - $LITE 称未见到如中方声称那样的产出（若虚假也无追责手段）。 重申了 CPO 相关激光器的护城河，光通信板块并未如某些空头声称的那样被中国产品淹没。 4. $MTSI 称许多客户因磷化铟(InP) DFB 激光器普遍短缺而紧急接触他们。 再次将 Sivers 置于该瓶颈中，使其可能获得更多客户需求。 在 $COHR ($725.4亿市值)、$LITE ($665.7亿市值)、$AVGO ($2.13万亿市值) 中： 能以约 $15亿市值获得西方四大 CPO 领导者之一的 $SIVE，非常特别。 感觉我的论点得到了验证： - 我预测的 CW 瓶颈 - CW 激光器瓶颈（至少对于第一代而言，只有少数 CPO 玩家） 现在只需等待下一代光架构转变的拐点。
英文原文
So this is just what I'm seeing with $SIVE and the CW DFB laser chokepoint right now. From optical earnings: 1. $LITE: unexpected demand and imbalance for UHP CW lasers. - Had ability to price up ASP for lasers. - Scale up CPO on track for H2 2027 shipments, called out any CPO scale up delay rumors as noise. Lumentum confirmed timelines (that CPO players like Sivers sold off of misleading reports from), high margins, and extreme demand for qualified CW lasers. 2. $AAOI: doesn’t have enough CW laser capacity because of too much optical transceiver demand. - Not meaningfully participating in first-gen CPO deployments, with $MTSI not looking like they're in it either but focusing on NPO. Haven't seen much with $SMTC after their HieFo acqusition. - Called lasers as the bottleneck within a 20-40% demand imbalance for transceivers. - Says customers approaching them every week asking them for supply + to move faster. AOI confirmed demand imbalances + bottlenecks for lasers. And we got an even smaller pool for first-gen CPO players. 3. Both $AAOI and $LITE claimed Chinese players were years behind for CPO lasers and far behind stated claims in qualified capacity. - $AAOI said 2-3 years+ behind with CPO lasers. - $LITE said they haven't seen anything like Chinese claims in terms of outputs (and no recourse if it's false). Reaffirms moat for CPO related lasers, and no flooding from some shortseller claims on the optical sector. 4. $MTSI said that many customers are approaching them with urgency due to the general supply shortage of indium phosphide DFB lasers. Again, puts Sivers in the that bottleneck, giving them likely more customer demand . Among $COHR ($72.54B), $LITE ($66.57B), $AVGO ($2.13T): It's very special you get one of the public 4 Western CPO leaders at a ~$1.5B MC with $SIVE. Feels like my thesis with both: - The CW bottleneck that I predicted - CW laser chokepoint (where there's only a few CPO players, at least for gen-1) Got validated from earnings, now it's just waiting for the inflection points of next optical architecture shifts.
-
毛利率骤降疑似库存减值，错失激进涨价良机。
@Schulz_Research 他们的毛利率似乎从 16.61% -> 15.22% -> 4.41%，这很可能是由于库存减值(margin liquidation)导致的。也许如果我们没有看到如此惊人的下滑，他们本可以推动激进式(activist style)的涨价。
英文原文
@Schulz_Research They went from 16.61% -> 15.22% -> 4.41% apparently, which was likely the margin liquidation. Maybe they could have pushed for activist style price hikes if we didn't see a surprising drop.
-
博主认同太阳诱电作为MLCC厂商对全球AI供应链的关键价值。
今日报道，Leopold 旗下的 Situational Awareness 收购了太阳诱电 (Taiyo Yuden, $6976) 11.62% 的股份。较 7 月 16 日的 5.99% 有所增加。我同意他的观点（如果他仍持有该仓位），即这家 MLCC（多层陶瓷电容器）制造商对全球 AI 供应链极具价值。https://t.co/fAQNpAFfhU
英文原文
It was reported today that Leopold’s Situational Awareness acquired 11.62% of Taiyo Yuden (6976). Up from 5.99% as of July 16th. I do agree with his position (if he still has it) in terms of how valuable this MLCC manufacturer is to global AI supply chains. https://t.co/fAQNpAFfhU
-
LITE财报证实CPO 27H2放量，CW激光供需失衡且中国厂商落后。
$LITE 财报电话会要点： - “我们对共封装光学(CPO)规模化部署的时间表可见度已提高。我们确信，2027年下半年我们的超高功率激光芯片需求将强劲增长。” Lumentum 确认其领先客户将于 2027 年下半年启动 CPO 规模化放量。 - “我们最近获得了首个外部光源(ELS)模块订单，将于 2027 年下半年交付。” ELS 行业放量时间表。 - “非平面光学(NPO)机会对我们完全是增量，显著增加了光学市场的总规模(TAM)。” 激光瓶颈俱乐部的 TAM 进一步扩大。 - “我们预计 1.6T 光模块的采用将从财年第一季度开始加速，并持续至 2027 年。” - “即使在连续波(CW)激光领域，我们对自己提价的能力也感到惊讶。” $SIVE 及其他 CW 激光玩家拥有积极的定价权。 - “因此，我们能够获得可观的价格溢价，并预计这种溢价将维持下去，即使这些中国厂商上线。我也提醒人们，我认为一些中国激光供应商目前并未在市场上实际交付，所以当它们抛出那些大数字时，没有追索权。迄今为止，我们在其产出方面尚未看到类似情况。” 中国厂商在激光/产能方面落后于市场预期，得到 $AAOI 和 $LITE 的证实。 - “不幸的是，我们在高功率激光的发货上远远落后。” “需求信号增加，相对于我们的供应能力，我们更加落后。” 超高功率(UHP) CW 激光产能存在极端供需失衡，EML 需求持续失衡。年底发货约 +5000 万美元 -> 1 亿美元+（“三位数季度”），进入 2027 年下半年和 2028 年更大的规模化需求。 - “所以，我认为过去三个月我们真正试图做的是确保更多的衬底供应”（因为供需失衡），“我们从 $AXTI 找到了额外的衬底帮助。他们是伟大的合作伙伴。” 磷化铟(InP)衬底瓶颈出现。 要点总结： - Lumentum 确认 CPO 2027 年下半年放量，驳斥任何“延迟”新闻为市场“噪音”。（一份延迟报告造成了巨大损害，Nvidia、Lumentum 等公司花了数周进行危机公关）。 - CW 激光需求在 2027 年下半年放量。 - 超高功率 CW 激光产能的极端供需失衡让 Lumentum 感到惊讶。 - 超高功率激光拥有极高利润率，并能对 CW 激光产能提价。 - 中国在激光/产能方面进一步落后。 基本上验证了西方 CW 激光玩家的时间表 + 需求/定价。 在主要放量开始之前，CW 激光的稀缺性已经发生……
英文原文
$LITE earnings transcript TLDRs: - "Our visibility into the timing of CPO scale-up deployments has also sharpened. We remain confident in a demand ramp for our ultra-high-power laser chips in the second half of calendar 2027" H2 2027 start of CPO scale up ramp confirmed from Lumentum for their lead customer. - "We were recently given our first external light source, or ELS, module purchase for delivery by the second half of calendar 2027" ELS industry ramp timelines - "The NPO opportunity is completely additive for us, significantly increasing the optical TAM." More TAM for laser chokepoint club - "we expect the 1.6T transceiver uptake to intensify starting in fiscal Q1 and sustain through calendar 2027." - "Even in CW, we’ve been surprised at our ability to price up" Positive pricing power for $SIVE and the other CW laser players. - "As a result, we are able to command a nice price premium that we expect to sustain, as these Chinese if these Chinese guys come online. I caution people also, I think people are some of these Chinese laser suppliers are not delivering in the market today, so they have there is no recourse when they throw out these big numbers. We have not seen anything like that to date in terms of their output." Chinese players are more behind than markets expect, corroborated by $AAOI and $LITE. - "We are way behind in our shipments, unfortunately, on high-powered lasers" "The demand signal has increased, and we are very much further behind relative to our ability to supply." Extreme demand imbalance for UHP CW laser capacity, continued demand imbalance for EML. Shipping roughly +$50M year end -> $100m+ ("triple digit quarter") into much larger H2 2027 and 2028 scale up demand,. - "So what we are trying to do, I think, really in the last three months is secure even more substrate supply" (because of demand imbalance), "we found additional substrate help from $AXTI They are a great partner." Hello InP substrate bottleneck. TLDR: - Lumentum CPO scale up H2 2027 shipments got confirmed, dismissed any "delay" news as market "noise". (one delay report caused so much damage, and it took Nvidia, Lumentum, and all these companies weeks to do damage control). - CW lasers demand ramp second half of 2027 - Extreme demand imbalance for UHP CW laser capacity surprised Lumentum - UHP lasers commands very high margins and is able to price up CW laser capacity. - China further behind in the laser/capacity angle. Basically just validated timelines + demand/pricing for Western CW laser players. CW laser scarcity is already happening before the main volume ramp even begins...
-
AI产业链各环节财报强劲，需求与订单爆发式增长。
今天AI主题的财报简直疯狂，涉及$CRWV、$SMCI和$LITE。 Coreweave：荒谬的~1040亿美元+积压订单，这还不包括Q3初新增的250亿美元+客户协议。 Neoclouds（如Nebius、Iren等）的计算需求传导效应巨大。 Supermicro：荒谬的650-720亿美元营收指引，新增600亿美元+订单... AI数据中心建设的传导效应极其巨大。 Lumentum：营收从8.08亿 -> 10.1亿 -> 12.5亿美元攀升，运营利润率逐季增长。 光子学玩家一直在疯狂印钞。 简而言之：AI建设的每一层都在疯狂爆发，且体现在财报中。
英文原文
Insane earnings today for the AI theme with $CRWV, $SMCI, and $LITE. Coreweave: Absurd ~$104B+ backlog, which doesn't include $25B+ of new customer agreements added in early Q3. Compute demand read through for Neoclouds is enormous (For Nebius, Iren and others) Supermicro: Absurd $65-72B in revenue guidance, adding $60B+ in new orders... AI DC buildout read through is just enormous. Lumentum: $808M -> $1.01B -> $1.25B revenue ramp, with operating margins growing quarter after quarter. Photonics players just keeps printing. TLDR: Every layer of the AI buildout goes brrrrr, and it's showing up in earnings.
-
AAOI产能受限，优先自供激光器，CPO部署短期承压。
@Berlinergy $AAOI：“我们根本无法生产足够的[共封装光学(CPO)激光器]来满足其当前第一代[CPO]部署的需求，因为产能确实不足。我们必须优先确保为自家光模块生产激光器。”这仅适用于早期CPO相关部署的初步解读。
英文原文
@Berlinergy $AAOI: "We just can’t make enough of them [CPO lasers] to be involved in their current first-generation [CPO] deployments because there’s just not enough capacity. We have to prioritize our ability to make lasers for our own transceivers first" This is just for early CPO related deployment read through.
-
博主坦言对采用率细节不熟，难以评估对POET等竞对的影响。
@NicolaRussoIT 我对采用率的具体细节不太熟悉，虽然浏览过 $ANET、$XPO 和 $MSA 的资料（我知道 $MSFT 是最公开表示支持的）……所以很难对 $POET 等其他参与者的影响给出很好的回答。https://t.co/Xi6zrmo5ha
英文原文
@NicolaRussoIT Not as familiar with adoption read through with $ANET XPO MSA (ik $MSFT has been the most openly supportive).. so can't really give a good answer to implications on other players like $POET. https://t.co/Xi6zrmo5ha
-
优必选IPO或提振机器人板块，哈默纳科长期受益于人形机器人规模化。
@Yangyftz 在我看来，这似乎是正常的市场波动。我认为优必选(Unitree)的成功IPO可能会在短期内提振整个机器人板块。无论如何，从长期来看，我认为哈默纳科(Harmonic Drive)将受益于人形机器人规模化至百万台级别，从而实现创纪录的营收。
英文原文
@Yangyftz Looks like normal market volatility to me. I think a successful IPO from Unitree might bring up the robotics sector as a whole near-term. Regardless, I see Harmonic Drive long-term to have record revenue numbers coming from humanoid ramp as robots scale up to the millions.
-
宇树IPO超额认购8000倍，或带动美国头部人形机器人公司关注。
呃……宇树科技(Unitree)的IPO在散户中超额认购超过8000倍。纯人形机器人公司的需求简直巨大？我个人加入了美国本土的Agility Robotics俱乐部（软银、$NVDA、$AMZN、富士康等），通过$CCXI以25亿美元投前估值参与。我的看法是，宇树科技可能以300亿美元以上（来自IPO前永续债）开盘，可能会在一两周内给领先的美国玩家带来更多关注。无论如何，这种需求简直荒谬。
英文原文
uhhh... the Unitree IPO is more than 8000 times oversubscribed by retail investors. The demand for pure play humanoid companies is absolutely enormous? I'm personally in the US-based Agility Robotics club (Softbank, $NVDA, $AMZN, Foxconn, etc), at $2.5B premoney via $CCXI. And my take is that Unitree likely opening at $30B+ (from pre-ipo perps), might bring the leading US players some more attention in a week or two. Regardless that's just absurd demand.
-
Riot获Anthropic巨额订单，AMD扩产，数据中心收入拐点预计2027下半年。
哇，$RIOT 宣布与 Anthropic 达成 91 亿美元的交易，潜在合同总额可能达 161 亿美元，期限长达 20 年。 $AMD 也行使了扩大其与 Riot 现有协议的期权。（他们仍有一个 1GW 的园区拥有意向书 (LOI) 等待租户入驻） 就时间线而言，似乎大多数数据中心 (Colo) 股票的收入拐点都将在 2027 年下半年到来？ （例如：Riot 与 Anthropic 的交易目标是在 2027 年 12 月交付首批 96MW，AMD 的 50MW 则在 2027 年 5 月） 看到像 $IREN 等前矿工们“长大成人”挺可爱的。
英文原文
Woah, $RIOT announced a $9.1B deal with Anthropic, with a possible contract extending to $16.1B, over 20Y. $AMD also exercised its option to expand its existing deal with Riot. (And they still have another 1 GW campus they have LOI with for a tenant) In terms of timelines, seem like most of the Colo basket have their revenue inflections hit H2 2027? (Eg. Riot Anthropic deal targets Dec 2027 for first 96 MW, AMD full 50 MW - May 2027) It’s cute to see all the former miners like $IREN and co. grow up.
-
光模块供需失衡且产能售罄，预计LITE财报强劲并作为行业风向标。
@00m00oo 我认为从 $AAOI 的财报中我们已经得到了太多关于光模块(Optical Transceivers)需求存在20-40%失衡以及激光器(Lasers)成为瓶颈的暗示。 而且 $POET 在其年度股东大会(AGM)上表示，未来两年三大云厂商的产能已完全售罄。 我通常不做财报涨跌预测，因为那大多时候就像抛硬币一样随机。但我可以说，除非有非常意外的情况，否则大部分定价调整在财报发布前就已经发生。 无论如何，我预计 $LITE 的财报会非常强劲，我主要将其作为其他激光器厂商的参考指标(read-through)。
英文原文
@00m00oo I think we already got too many hints from $AAOI earnings about demand 20-40% imbalance for optical transivers with lasers as a bottleneck. And $POET stating big 3 are completely sold out of capacity next 2 years during their AGM. I don’t give earnings up or down predictions since it’s a coin flip most of the time. But I can say that a lot of pricing happens before earnings, unless there’s something very unexpected. Regardless I expect $LITE earnings to come out really strong, and I primary use it as a read through for your other laser players.
-
OCP峰会及财报周催化光模块与机器人板块，Unitree IPO或带动机器人行情。
近期的一些事件： - 明天是OCP亚太峰会（Ayar、Lightmatter、$AMD、$NVDA），你的共封装光学(CPO)概念股正在发布公告/更新。 这应该是某些光模块玩家的催化剂。 - 财报周：$ASTS、$RKLB今天发布（太空），$LITE周二（光子学），$NBIS在本周中段（Neocloud），还有更多。 - Unitree IPO认购今天开启，预计本月上市。 如果开盘良好，应是人形机器人+机器人板块的潜在催化剂，例如 $CCXI。 接下来的一周很有趣。
英文原文
Just some near term events: - OCP APAC tomorrow (Ayar, Lightmatter, $AMD, $NVDA) and your CPO players are giving announcements/updates. This should be a catalyst for certain optical players. - Earnings week: with $ASTS, $RKLB reporting today (space), $LITE on Tuesday (photonics), $NBIS in the middle of the week (Neocloud), and more. - Unitree IPO subscriptions opened up today and Listing is expected this month. Should be a potential catalyst for the humanoid + robotics sector if it opens up well eg. $CCXI. Fun week ahead.
-
InP激光器短缺利好SIVE，可套用AAOI产能模型。
我认为现在是重新审视 $SIVE 的时机，其年化产能收入的中位预测约为 4.27 亿美元。 鉴于近期的行业财报： > $AAOI 指出光模块（transceivers）需求存在 20-40% 的失衡（激光器是瓶颈）。 > $MTSI 表示许多“客户因磷化铟（InP）DFB 激光器普遍短缺而紧急联系我们”（在其他产品线中）。 > 美国提议禁止新的中国光模块（中际旭创/新易盛）。 > AOI 因激光器被分配给光模块，未实质性参与第一代共封装光学（CPO）部署。 解读是：可以将适用于 $AAOI 的产能-需求吸收模型，同样应用于 Sivers 等其他激光器厂商。 鉴于 InP CW DFB 产能的广泛短缺和需求失衡。
英文原文
I think it’s a good time to revisit $SIVE ~$427m/yr midpoint capacity revenue modeled projections. Given recent industry earnings: > $AAOI cited +20-40% demand imbalance for transceivers (with lasers as the bottleneck). > $MTSI saying many "Customers are coming to us with urgency due to the general supply shortage of indium phosphide DFB lasers" (in other product lines) > US proposal ban on new Chinese optical transceivers (Innolight/Eoptolink) > AOI no meaningful participation in first-gen CPO deployments due to lasers being allocated toward transceivers. The read through is that it’s possible to apply the same capacity-demand absorption modeling applying to $AAOI, but for other laser players like Sivers too. Given the widespread shortage and demand imbalance for InP CW DFB capacity.
-
白宫投资关键矿物以加速开发并降低供应链风险。
来了，白宫终于向关键矿物/材料领域投入更多资源。惊人的政策举措，简而言之： - $WWR 获得 2500 万美元（石墨） - $SRL (ASX) 获得 4 亿美元（钪） - $FEAM 获得 800 万美元（硼） - $HREE 获得 480 万美元（磁性稀土） 以上为上市公司。此外还有对 Niron Magnetics 的 1.5 亿美元或对 Standard Bauxite 的 8500 万美元等更多私人投资。 这对美国政府来说简直是零钱，却能带来下游应用的巨大增长。应在资金规模上做得更多以加速开发并降低供应链风险（我不持有上述任何股票，仅支持该政策举措），但这是个很好的公告。
英文原文
There we go, White House finally invests in more breath in critical minerals/materials. Amazing policy move, as a TLDR: - $WWR receives $25M (graphite) - $SRL (ASX) receives $400M (Scandium) - $FEAM receives $8M (Boron) - $HREE receives $4.8M (magnet rare earths) out of the public companies. With more private investments from $150 million into Niron Magnetics or $85 million into Standard Bauxite. It's literally spare change to the US gov, for ENORMOUS amount of downstream applications. More should be done with funding amounts to accelerate development and derisk supply chains (don't own any of the above, just support the policy move), but great announcement.
-
激光器及InP衬底未来2-3年或现短缺，CPO扩产加剧瓶颈。
@SL2056 @Sofigoodboy 好问题！这是逐年变化的，很难从2026年预测到2030年的短缺，但这绝对是一个结构性的多年需求周期。 我想指出的是，激光器（lasers）在特定领域很可能在未来2-3年面临极端短缺，尤其是在共封装光学(CPO)规模化初期至少如此。 例如，CPO激光器市场所需的产能“比今天大8到10倍”，并补充说：“我认为……完全没影响，因为需求远大于全球产能。” 至于磷化铟(InP)衬底，$AAOI 表示2027年没问题，但由于其关键性希望组建合资企业。 $AXTI 看起来只是逐年倍增产能，具体取决于你问谁。 一些台湾外延片(epiwafer)厂商称InP衬底面临极端短缺，而它们正是激光器厂商的上游。 你的激光器厂商如 $AAOI 和 $MTSI 表示他们没问题。 无论如何，我们看到这转化为 $AXTI 的收入拐点（2027年约1.3亿美元/季度），但我预计鉴于其市场地位，平均售价(ASP)一路上涨。
英文原文
@SL2056 @Sofigoodboy Good question! This something year-by-year, can't really predict shortages into 2030 from 2026, but it's definitely a structural multi-year demand cycle. Something that I want to flag is that it looks like lasers in specific would likely have extreme shortages for the next 2-3 years, especially during CPO scale up at the very least. eg. CPO laser market would require capacity "8 to 10x bigger compared to today," and added, "I think… no effect at all because the demand is much bigger than the worldwide capacity." As for InP substrates, $AAOI said they were fine for 2027 calendar year but wanted to form JVs because of likely how critical they are since. $AXTI looked like they were just multiplying capacity year after year and depends on who you ask.. Some of the Taiwan epiwafer players say it's extreme shortages for InP substrates, when they feed into your laser players. Your laser players like $AAOI and $MTSI say they're fine. Regardless, we see that convert into revenue inflection points with AXTI anyway (~$130m/quarter in 2027), but I'm expecting ASP to be hiked along the way given their positioning.
-
AAOI财报揭示DSP/TIA瓶颈利好同行，且营收增速惊人。
以下是 $AAOI 财报的一些要点摘要： - 他们也指出了数字信号处理(DSP)和收发器接口放大器(TIA)的瓶颈，这对 $MXL、$SMTC 和 $MTSI 等公司来说是积极的行业利好信号。 - 关于营收增长，他们预计第四季度营收将超过 5 亿美元，这种增长速度简直令人难以置信。 供参考： 第二季度：1.919 亿美元 第三季度：约 2.55 亿-2.9 亿美元 第四季度：5 亿美元以上 到 2027 年中：季度营收年化运行率约 14.1 亿美元 这些光通信玩家强劲的营收爬坡速度总是让我印象深刻。
英文原文
Some more TLDR takeaways from $AAOI ER: - They also flagged DSP and TIA bottlenecks, which is a positive industry read through for names like $MXL, then $SMTC and $MTSI. - For revenue growth, they're expecting more than $500 million revenue Q4, which is absurd growth. For reference: Q2: $191.9M Q3: ~$255M-$290M Q4: $500M+ By mid-2027: ~$1.41B quarterly revenue run-rate Always impressed by the revenue ramp from some of these optical players.
-
Rosenblatt 光通信调研精准，AAOI 财报证实中国 CPO 激光器落后。
我通常喜欢调侃卖方分析师，但 Rosenblatt 对光通信标的的渠道调研（Channel Checks）确实非常出色，他们的报告是我少数愿意讨论的。$AAOI、$LITE、$SIVE 以及激光板块已开始在其预估的时间窗口内恢复。例如，上个月他们提到：“多位空头表示他们可能会在 7 月底和 8 月初平仓”。他们可能误判了 $AMD 会是 $AAOI 的首个共封装光学(CPO) 客户……因为 AAOI 表示他们将缺席第一代 CPO（也许是未来几代？）。但他们关于中国 CPO 激光器定位（例如落后 2-3 年）的许多观点，今天被 AAOI 的财报逐字证实了。
英文原文
I usually make fun of sellside, but Rosenblatt has pretty goated channel checks on optical names, and their reports are one of the few I like talking about. $AAOI, $LITE, $SIVE, and the laser party has started to recover around the est. timing windows. eg. last month: "Multiple short sellers told them they will likely close their positions... late July and early August". They might have missed that they believed $AMD would be $AAOI's first CPO customer... since AAOI said they would be missing from first-gen CPO (maybe future gen?) But lot of their talking points about China CPO laser positioning (eg. 2-3 years behind) got corroborated word-for-word from AAOI earnings today.
-
宇树科技拟90亿估值IPO，衍生品隐含市值360亿，对比美国同行定价。
Unitree（宇树科技），中国的人形机器人（Humanoid Robot）龙头，本月将以90亿美元估值（~$9B valuation）上市！（~$62亿最初于3月申报）。衍生品市场（Derivative markets）定价隐含开盘市值为360.4亿美元，约为上市价的4倍。$CCXI / Agility Robotics，美国首家上市的纯人形机器人龙头，也将在第四季度晚些时候上市，上市前估值约25亿美元。看看市场如何对美国与中国的人形机器人龙头进行定价，将很有趣。
英文原文
Unitree, China's humanoid leader, is set to IPO this month at a $9B valuation! (~$6.2B originally per March filing). Derivative markets are pricing open at an implied $36.04B MC, roughly ~4X listing price. $CCXI / Agility Robotics, the first US publicly listed pure play humanoid leader, is also going public later in Q4, at a ~$2.5B pre-money valuation. It will be interesting to see how markets price in America vs. Chinese Humanoid leaders.
-
Sivers需向下游拓展以扩大市场，因向下游比向上游更容易。
@homeboyrichie 目前确实如此，因为 Lumilens 拥有直接的超大规模客户和数十亿美元的采购协议。而 $SIVE 是一家上游激光器供应商。Sivers 需要向下游拓展，通过销售光引擎、ELS 或像 $LITE 在并购 Cloud Light 后那样销售完整的光模块，以捕获更大的总可服务市场(TAM)。我的观点是，鉴于合格的激光器供应商数量有限，向下游拓展比向上游更容易。
英文原文
@homeboyrichie For now yes, because Lumilens has a direct hyperscaler customer and multi-billion dollar purchase agreements. While $SIVE is an upstream laser supplier. Sivers needs to work its way downstream to capture more TAM with selling optical engines, ELS, or complete optical transceivers like $LITE did after M&A eg. Cloud Light. My opinion is that it’s easier to move downstream than upstream as you seen with the limited amount of qualified laser suppliers out there.